Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
Centro de investigación
Universidade Federal do Paraná
Curitiba, BrasilPublicacións en colaboración con investigadores/as de Universidade Federal do Paraná (14)
2023
-
Age Differences in Comorbidities, Presenting Symptoms, and Outcomes of Influenza Illness Requiring Hospitalization: A Worldwide Perspective From the Global Influenza Hospital Surveillance Network
Open Forum Infectious Diseases
-
Criteria to evaluate efficacy of biologics in asthma: a Global Asthma Association survey
Expert Review of Respiratory Medicine, Vol. 17, Núm. 6, pp. 507-516
-
Diminishing benefits of urban living for children and adolescents’ growth and development
Nature, Vol. 615, Núm. 7954, pp. 874-883
2021
-
Consensus on diagnosis and management of Cushing's disease: a guideline update
The lancet. Diabetes & endocrinology, Vol. 9, Núm. 12, pp. 847-875
-
Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight
eLife, Vol. 10
-
Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?
Journal of the Endocrine Society, Vol. 5, Núm. 3
2020
-
A consensus on the diagnosis and treatment of acromegaly comorbidities: An update
Journal of Clinical Endocrinology and Metabolism, Vol. 105, Núm. 4, pp. E937-E946
-
Multidisciplinary management of acromegaly: A consensus
Reviews in Endocrine and Metabolic Disorders, Vol. 21, Núm. 4, pp. 667-678
2019
-
Changing rate of serious infections in biologic-exposed rheumatoid arthritis patients. Data from South American registries BIOBADABRASIL and BIOBADASAR
Clinical Rheumatology, Vol. 38, Núm. 8, pp. 2129-2139
2018
-
Growth hormone research society perspective on biomarkers of gh action in children and adults
Endocrine Connections, Vol. 7, Núm. 3, pp. R126-R134
2016
-
Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations
European Journal of Endocrinology
2014
-
Analysis of infections and all-cause mortality in phase II, phase III, and long-term extension studies of tofacitinib in patients with rheumatoid arthritis
Arthritis and Rheumatology, Vol. 66, Núm. 11, pp. 2924-2937
-
BIOBADASER, BIOBADAMERICA, and BIOBADADERM: Safety registers sharing commonalities across diseases and countries
Clinical and Experimental Rheumatology, Vol. 32, pp. S163-S167
2012
-
Reconstructing Native American population history
Nature, Vol. 488, Núm. 7411, pp. 370-374